(CDRE) Cadre Holdings - Ratings and Ratios
Body Armor, Survival Suits, Bomb Suits, Duty Gear, Blast Protection
CDRE EPS (Earnings per Share)
CDRE Revenue
Description: CDRE Cadre Holdings
Cadre Holdings, Inc. is a leading manufacturer and distributor of safety equipment and related products that protect users in hazardous situations globally. The companys product portfolio includes body armor, survival suits, and duty gear, serving first responders, federal agencies, and various industries such as nuclear, defense, and oil and gas. With a strong presence in the United States and international markets, Cadre Holdings has established itself as a trusted provider of protective equipment and specialized gear.
The companys diverse product offerings cater to a wide range of customers, including law enforcement, fire and rescue, and emergency medical technicians. Cadre Holdings products are designed to provide protection and support in life-threatening situations, leveraging brands such as Safariland and Protech Tactical. The companys commitment to delivering high-quality products has earned it a reputation as a reliable partner for government agencies and industries requiring specialized equipment.
Analyzing the
Combining the insights from
CDRE Stock Overview
Market Cap in USD | 1,242m |
Sub-Industry | Industrial Machinery & Supplies & Components |
IPO / Inception | 2021-11-04 |
CDRE Stock Ratings
Growth Rating | 33.4% |
Fundamental | 61.6% |
Dividend Rating | 63.2% |
Total Return vs S&P 500 | -27.7% |
Analyst Rating | 4.43 of 5 |
CDRE Dividends
Dividend Yield 12m | 1.18% |
Yield on Cost 5y | 2.56% |
Annual Growth 5y | 44.63% |
Payout Consistency | 99.0% |
Payout Ratio | 38.5% |
CDRE Growth Ratios
Growth Correlation 3m | -56.3% |
Growth Correlation 12m | -54.5% |
Growth Correlation 5y | 78.7% |
CAGR 5y | 20.29% |
CAGR/Max DD 5y | 0.51 |
Sharpe Ratio 12m | 0.53 |
Alpha | -31.57 |
Beta | 0.982 |
Volatility | 50.06% |
Current Volume | 441.3k |
Average Volume 20d | 278.5k |
Stop Loss | 27.4 (-6.3%) |
Signal | -0.37 |
Piotroski VR‑10 (Strict, 0-10) 5.0
Net Income (38.1m TTM) > 0 and > 6% of Revenue (6% = 34.4m TTM) |
FCFTA 0.04 (>2.0%) and ΔFCFTA -3.93pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
NWC/Revenue 48.02% (prev 37.97%; Δ 10.05pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
CFO/TA 0.05 (>3.0%) and CFO 38.5m > Net Income 38.1m (YES >=105%, WARN >=100%) |
Net Debt (193.3m) to EBITDA (84.3m) ratio: 2.29 <= 3.0 (WARN <= 3.5) |
Current Ratio 3.59 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
Outstanding Shares last Quarter (40.9m) change vs 12m ago 0.21% (target <= -2.0% for YES) |
Gross Margin 41.49% (prev 40.47%; Δ 1.02pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
Asset Turnover 80.93% (prev 85.70%; Δ -4.77pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
Interest Coverage Ratio 6.79 (EBITDA TTM 84.3m / Interest Expense TTM 10.0m) >= 6 (WARN >= 3) |
Altman Z'' 3.05
(A) 0.35 = (Total Current Assets 381.0m - Total Current Liabilities 106.1m) / Total Assets 794.4m |
(B) 0.02 = Retained Earnings (Balance) 19.8m / Total Assets 794.4m |
(C) 0.10 = EBIT TTM 67.9m / Avg Total Assets 707.5m |
(D) 0.05 = Book Value of Equity 22.4m / Total Liabilities 462.0m |
Total Rating: 3.05 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 61.58
1. Piotroski 5.0pt = 0.0 |
2. FCF Yield 2.35% = 1.18 |
3. FCF Margin 5.84% = 1.46 |
4. Debt/Equity 0.95 = 2.07 |
5. Debt/Ebitda 3.74 = -2.45 |
6. ROIC - WACC 0.28% = 0.35 |
7. RoE 12.08% = 1.01 |
8. Rev. Trend 64.92% = 3.25 |
9. Rev. CAGR 12.09% = 1.51 |
10. EPS Trend 28.25% = 0.71 |
11. EPS CAGR 31.82% = 2.50 |
What is the price of CDRE shares?
Over the past week, the price has changed by +2.85%, over one month by -9.93%, over three months by -17.23% and over the past year by -15.84%.
Is Cadre Holdings a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CDRE is around 26.79 USD . This means that CDRE is currently overvalued and has a potential downside of -8.41%.
Is CDRE a buy, sell or hold?
- Strong Buy: 4
- Buy: 2
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the CDRE price?
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 41.8 | 43% |
Analysts Target Price | 42 | 43.6% |
ValueRay Target Price | 29.7 | 1.5% |
Last update: 2025-08-10 02:07
CDRE Fundamental Data Overview
CCE Cash And Equivalents = 137.5m USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 32.8495
P/E Forward = 24.0385
P/S = 2.1695
P/B = 3.7366
Beta = 1.313
Revenue TTM = 572.6m USD
EBIT TTM = 67.9m USD
EBITDA TTM = 84.3m USD
Long Term Debt = 298.9m USD (from longTermDebt, last quarter)
Short Term Debt = 16.3m USD (from shortTermDebt, last quarter)
Debt = 315.1m USD (Calculated: Short Term 16.3m + Long Term 298.9m)
Net Debt = 193.3m USD (from netDebt column, last quarter)
Enterprise Value = 1.42b USD (1.24b + Debt 315.1m - CCE 137.5m)
Interest Coverage Ratio = 6.79 (Ebit TTM 67.9m / Interest Expense TTM 10.0m)
FCF Yield = 2.35% (FCF TTM 33.4m / Enterprise Value 1.42b)
FCF Margin = 5.84% (FCF TTM 33.4m / Revenue TTM 572.6m)
Net Margin = 6.65% (Net Income TTM 38.1m / Revenue TTM 572.6m)
Gross Margin = 41.49% ((Revenue TTM 572.6m - Cost of Revenue TTM 335.0m) / Revenue TTM)
Tobins Q-Ratio = 63.50 (Enterprise Value 1.42b / Book Value Of Equity 22.4m)
Interest Expense / Debt = 1.14% (Interest Expense 3.59m / Debt 315.1m)
Taxrate = 33.36% (from yearly Income Tax Expense: 18.1m / 54.2m)
NOPAT = 45.2m (EBIT 67.9m * (1 - 33.36%))
Current Ratio = 3.59 (Total Current Assets 381.0m / Total Current Liabilities 106.1m)
Debt / Equity = 0.95 (Debt 315.1m / last Quarter total Stockholder Equity 332.5m)
Debt / EBITDA = 3.74 (Net Debt 193.3m / EBITDA 84.3m)
Debt / FCF = 9.42 (Debt 315.1m / FCF TTM 33.4m)
Total Stockholder Equity = 315.5m (last 4 quarters mean)
RoA = 4.80% (Net Income 38.1m, Total Assets 794.4m )
RoE = 12.08% (Net Income TTM 38.1m / Total Stockholder Equity 315.5m)
RoCE = 11.05% (Ebit 67.9m / (Equity 315.5m + L.T.Debt 298.9m))
RoIC = 8.12% (NOPAT 45.2m / Invested Capital 557.2m)
WACC = 7.83% (E(1.24b)/V(1.56b) * Re(9.63%)) + (D(315.1m)/V(1.56b) * Rd(1.14%) * (1-Tc(0.33)))
Shares Correlation 5-Years: 100.0 | Cagr: 8.18%
Discount Rate = 9.63% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 74.36% ; FCFE base≈40.3m ; Y1≈44.5m ; Y5≈57.7m
Fair Price DCF = 18.72 (DCF Value 761.2m / Shares Outstanding 40.7m; 5y FCF grow 12.10% → 3.0% )
Revenue Correlation: 64.92 | Revenue CAGR: 12.09%
Revenue Growth Correlation: -5.58%
EPS Correlation: 28.25 | EPS CAGR: 31.82%
EPS Growth Correlation: -49.57%
Additional Sources for CDRE Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle